Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Open Access
- 6 August 2018
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 18 (1) , 366
Abstract
Some children are prone to recurrent invasive pneumococcal disease (rIPD) and of these, some respond insufficiently to standard pneumococcal vaccination. Little is known about how to handle these children and if they benefit from additional vaccination. Here, we present results from a nationwide study of pediatric rIPD including data on serotype-specific vaccination response to pneumococcal polysaccharide vaccination (PPV23) and pneumococcal conjugate vaccination (PCV7/13). A retrospective, population-based study was conducted using The National Streptococcus pneumoniae Registry, which contains laboratory-confirmed data from all cases of IPD in Denmark. From January 1980–June 2013 all children aged 0–15 years with rIPD were identified. Clinical data and data on serotype-specific pneumococcal antibody response were collected. Over the years quantification of pneumococcal antibodies varied from being presented in arbitrary units (ELISA), in μg/ml (WHO ELISA) and lately in μg/ml based on Luminex technology. 2482 children were diagnosed with IPD and 75 episodes of rIPD were documented in 59 children. An underlying disease was documented in 45 (76%) children. Vaccination data were available for 26 children; 11 were vaccinated solely with PPV23, 8 with a combination of PPV23 + PCV7, 5 with PCV7 and 2 with PCV13. In total, nine responded to PPV23 vaccination and ten were PPV23 non-responders. Of the 15 PCV vaccinated children, two children responded subnormal to PCV7. Among PPV23 non-responders, five responded to subsequent PCV vaccination. In our population-based study of children with rIPD 53% of the children responded insufficiently to PPV23 vaccination. PPV23 non-responders benefitted from PCV vaccination.Keywords
This publication has 37 references indexed in Scilit:
- Specific Antibody Deficiency: Controversies in Diagnosis and ManagementFrontiers in Immunology, 2017
- Recurrent Invasive Pneumococcal Disease in Children: Underlying Clinical Conditions, and Immunological and Microbiological CharacteristicsPLOS ONE, 2015
- Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and MortalityClinical Infectious Diseases, 2014
- Serotype-Specific Anti-Pneumococcal IgG and Immune Competence: Critical Differences in Interpretation Criteria When Different Methods are UsedJournal of Clinical Immunology, 2012
- Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programmeVaccine, 2012
- Serologic response to a 23‐valent pneumococcal vaccine administered prior to autologous stem cell transplantation in patients with multiple myelomaAPMIS, 2012
- Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United KingdomThe Pediatric Infectious Disease Journal, 2010
- Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccineVaccine, 2007
- Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infectionClinical Microbiology and Infection, 2005
- Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiencyThe Journal of Pediatrics, 1997